Edinburgh Research Explorer

Dr Stefan Symeonides

Senior Clinical Lecturer in Medical Oncology

  1. 2020
  2. Different independent associations of depression and anxiety with survival in patients with cancer

    Walker, J., Magill, N., Mulick, A., Symeonides, S. N., Gourley, C., Toynbee, M., van Niekerk, M., Burke, K., Quartagno, M., Frost, C. & Sharpe, M., 18 Aug 2020, In : Journal of Psychosomatic Research.

    Research output: Contribution to journalArticle

  3. 2018
  4. Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT oncology-2 and 3 trials

    Mulick, A., Walker, J., Puntis, S., Symeonides, S., Gourley, C., Burke, K., Wanat, M., Frost, C. & Sharpe, M., 14 Nov 2018, In : Journal of Psychosomatic Research.

    Research output: Contribution to journalArticle

  5. Does depression treatment improve the survival of depressed cancer patients? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

    Mulick, A., Walker, J., Puntis, S., Burke, K., Symeonides, S., Gourley, C., Wanat, M., Frost, C. & Sharpe, M., 12 Mar 2018, In : Lancet Psychiatry.

    Research output: Contribution to journalArticle

  6. 2017
  7. 1211TiPFAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition

    Symeonides, S., Evans, T. R. J., Coyle, V., Serrels, A., Thomson, F., Currie, D., Dillon, S., Paul, J., Fennell, D. A. & Ottensmeier, C., 1 Sep 2017, In : Annals of oncology. 28, suppl_5

    Research output: Contribution to journalMeeting abstract

  8. FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer

    Symeonides, S. N., Anderton, S. M. & Serrels, A., 21 Feb 2017, In : Journal for immunotherapy of cancer. 5, p. 17

    Research output: Contribution to journalArticle

  9. 2016
  10. Continual reassessment method for dose escalation clinical trials in oncology: A comparison of prior skeleton approaches using AZD3514 data

    James, G. D., Symeonides, S. N., Marshall, J., Young, J. & Clack, G., 31 Aug 2016, In : BMC Cancer. 16, 1, 703.

    Research output: Contribution to journalArticle

  11. 2015
  12. Ovarian Cancer Molecular Stratification and Tumor Heterogeneity: A Necessity and a Challenge

    Symeonides, S. & Gourley, C., 21 Oct 2015, In : Frontiers in Oncology. 5

    Research output: Contribution to journalArticle

  13. Abstract CT329: Phase I study of the PI3Kβ/δ inhibitor AZD8186 in patients with advanced castration resistant prostate cancer, triple negative breast cancer, squamous non-small cell lung cancer or PTEN deficient solid tumors: update from dose-finding

    Siu, L. L., De Bono, J., Wisinski, K. B., Higano, C. S., Cook, N., De Miguel Luken, M. J., Kumar, R., Lang, J., Chatta, G. S., Tolaney, S. M., Symeonides, S. M., Morrison, G., Mitchell, P. D., Brooks, D. G. & Shapiro, G. I., 1 Aug 2015, In : Cancer Research. 75, 15 Supplement, p. CT329-CT329

    Research output: Contribution to journalMeeting abstract

  14. 2014
  15. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer

    Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., Murray, G., Sharpe, M. & SMaRT (Symptom Management Research Trials) Oncology-3 Team, 1 Sep 2014, In : The Lancet Oncology. 15, 10, p. 1168-76 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next